CommercialCoverageHigh impact
Prostate Cancer Screening (CPB 0521, reviewed 2025-11-25)
Aetna·Urology, Oncology, Internal Medicine +2 more·Medical Policy
Effective date
Nov 25, 2025
We identified it
Aug 14, 2026
Summary
Aetna's updated Prostate Cancer Screening policy (CPB 0521) clarifies coverage for PSA screening and digital rectal examinations while establishing a comprehensive list of experimental/unproven tests that are NOT covered. The policy maintains coverage for standard PSA testing (CPT 84152, 84153, 84154) and DRE (G0102, G0103) for eligible age groups, but explicitly excludes 25+ alternative screening tests including PCA3, four-kallikrein panel, Stockholm3, and genetic-based screening tests. Billing teams must immediately stop submitting claims for the listed experimental codes and ensure claims use only the covered CPT/HCPCS codes when medical necessity criteria are met.
Action Required
Effective immediately (2025-11-25): Billing team must perform the following: (1) Update billing software to DENY and reject all claims for the 25+ experimental/investigational prostate cancer screening codes listed in the policy, including 0021U, 0133U, 0433U, 0495U, 81210, 81313, 81539, 83520, 84255, and all related molecular cytogenetics codes (88271-88275, 88291). (2) Configure system to ONLY allow billing for covered codes (84152, 84153, 84154, G0102, G0103) when the following criteria are documented: patient age 45+ (average risk) or 40+ (high-risk: African-American or family history), with life expectancy ≥10 years if age 75+. (3) Create a claim-scrubbing rule to automatically flag and reject any of the excluded tests before submission. (4) Notify all providers in urology and primary care specialties of the non-covered tests list via email with specific code list attached. (5) Update encounter forms and EMR templates to remove checkboxes for experimental tests (PCA3, four-kallikrein panel, Stockholm3, genetic screening, etc.). (6) Train billing staff to educate patients at check-in that experimental prostate screening tests are not covered by Aetna and patient will be responsible for full cost if pursued. Failure to implement these changes will result in: (a) claim denials that cannot be appealed, (b) patient balance billing issues, (c) compliance violations. Priority: Complete software updates and provider notification within 5 business days.